C & S PHARMACY LIMITEDActive

Company number 07055667Private limited companyIncorporated 2009

Key figures

£1,469,140-4.8%
Net assets 2025/26
+8.8%
Average annual growth 2020/21–2025/26
0500 k1 m1.5 m2 m2020/212021/222023/242024/252025/26

Like most small UK companies, C & S PHARMACY LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
01 m2 m3 m2020/212021/222023/242024/252025/26
Filed accounts2020/21–2025/26
2020/212021/222023/242024/252025/26
Cash at bank and in hand66,213115,567124,250123,823164,530
Total assets2,318,8482,305,8332,233,0862,159,8162,113,754
Total liabilities————644,614
Net assets / total equity1,046,7831,173,3101,482,9481,543,6111,469,140
Average number of employees129997

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: C & S PHARMACY LIMITED

Company

C & S PHARMACY LIMITED is a private limited company registered with Companies House under company number 07055667. It was incorporated on 23 Oct 2009. Its status is active. The registered office is in Preston (PR1). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730).

Accounts

The latest accounts in the database are for 2025/26 (period ending 31 Jan 2026); the company files small company accounts (filleted). Net assets were £1,469,140, down 4.8% on the previous year. Cash at bank and in hand was £164,530. Total assets were £2,113,754 and total liabilities £644,614. The company had an average of 7 employees. Figures are available for 5 financial years (2020/21–2025/26).

Control and charges

2 persons with significant control are registered. 2 of 3 registered charges are outstanding.

Filing deadlines

The next accounts are due by 31 Oct 2027. The next confirmation statement is due by 9 Nov 2026.